Organovo Holdings Company

Organovo develops a range of tissue and disease models for medical research and therapeutic applications.

Founded Date: 2007
Total Funding: $117.4M
Employee Number: 51-100
Funding Status: IPO
Technology: Others
Last Funding Type: Series E
Investors Number: 2
Industry: PharmTech
Headquarters: San Diego, California, United States
Estimated Revenue: $1M to $10M